• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[前列腺素E1栓剂在妊娠中期和晚期治疗性终止妊娠中的应用。附46例报告]

[Use of prostaglandin E1 ovules in the therapeutic interruption of pregnancy in the 2d and 3d trimesters. Apropos of 46 cases].

作者信息

Monnier J C, Caron-Grillet C, Vinatier D, Patey-Savatier P, Maunoury-Lefebvre C

出版信息

Rev Fr Gynecol Obstet. 1987 Mar;82(3):195-8.

PMID:3589358
Abstract

46 late interruptions of pregnancy (16 to 33 weeks of amenorrhea) were performed with the use of prostaglandins E1 ovules, of 1 mg, placed in the posterior vaginal cul-de-sac every 12 hours. It concerned 13 deaths in utero or extremely premature rupture of the membranes, 25 fetal indications (9 chromosomal abnormalities and 16 severe malformations), and 8 maternal indications. The efficacy was good either with ovules alone (84.7%) or associated with a balloon probe (5.3%). Expulsion is faster in the case of fetal deaths (average = 8 hours), than in therapeutic interruptions of pregnancy (average = 20 hours). The necessary doses did not exceed 3 mg of PgE1. There were very few side effects, essentially gastro-intestinal in nature and the course was simple. No obstetrical complication was noted. This method is therefore particularly effective with minimal side effects. Easy to use, it must be reserved for very precise indications.

摘要

使用1毫克前列腺素E1栓剂,每12小时放置于阴道后穹窿,对46例妊娠中期(闭经16至33周)进行了引产。其中包括13例宫内死亡或胎膜极早破裂、25例胎儿指征(9例染色体异常和16例严重畸形)以及8例母体指征。单独使用栓剂(84.7%)或联合球囊探针(5.3%)的效果均良好。胎儿死亡情况下的排出速度更快(平均 = 8小时),而治疗性引产时排出速度较慢(平均 = 20小时)。所需剂量未超过3毫克前列腺素E1。副作用极少,主要为胃肠道反应,且过程简单。未观察到产科并发症。因此,该方法特别有效且副作用最小。使用方便,但必须严格用于非常明确的指征。

相似文献

1
[Use of prostaglandin E1 ovules in the therapeutic interruption of pregnancy in the 2d and 3d trimesters. Apropos of 46 cases].[前列腺素E1栓剂在妊娠中期和晚期治疗性终止妊娠中的应用。附46例报告]
Rev Fr Gynecol Obstet. 1987 Mar;82(3):195-8.
2
[A new prostaglandin E1 analog in late interruption of pregnancy, in utero deaths and very premature ruptures of the membranes. Apropos of 117 cases].[一种新型前列腺素E1类似物用于晚期妊娠中断、宫内死亡及胎膜过早破裂。附117例报告]
J Gynecol Obstet Biol Reprod (Paris). 1984;13(8):939-46.
3
[Interruption of the second and third trimester of a normal and missed pregnancy by extraamnial prostaglandin E administration combined with oxytocin infusion (author's transl)].经羊膜外给予前列腺素E联合静脉滴注缩宫素中断正常及稽留妊娠的中晚期妊娠(作者译)
Cesk Gynekol. 1979 Apr;44(3):179-82.
4
[Antiprogesterone for medical abortion].
Georgian Med News. 2006 Jun(135):24-8.
5
Termination of normal and pathological pregnancy with Sulprostone.使用磺前列酮终止正常及病理性妊娠。
Acta Chir Hung. 1986;27(3):151-6.
6
The use of 15-methylated derivative of prostaglandin F2a for the therapeutic termination of pregnancy and management of late fetal death.前列腺素F2a的15-甲基化衍生物用于治疗性终止妊娠及处理晚期胎儿死亡。
Int Surg. 1984 Jan-Mar;69(1):63-8.
7
Therapeutic termination of second trimester pregnancies with low dose misoprostol.用低剂量米索前列醇治疗终止中期妊娠
J Coll Physicians Surg Pak. 2006 Jul;16(7):464-7.
8
Intraamniotic prostaglandin F2 alpha for pregnancy termination in the second and early third trimesters of pregnancy.
J Reprod Med. 1997 Apr;42(4):235-8.
9
[Oxytocin and misoprostol administered intravaginally for termination of pregnancy at 13 to 29 weeks of amenorrhea. A prospective randomized trial].[阴道内给予缩宫素和米索前列醇用于终止闭经13至29周妊娠。一项前瞻性随机试验]
J Gynecol Obstet Biol Reprod (Paris). 2001 Sep;30(5):439-43.
10
[Medical abortion in the second and third trimester. Report of 125 indications from 1992 to 1995].
J Gynecol Obstet Biol Reprod (Paris). 1999 Jun;28(3):245-52.